Larotrectinib (Compound)

Synonyms:Larotrectinib, LOXO-101, 1223403-58-4, ARRY-470, (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, LOXO 101, UNII-PF9462I9HX, LOXO101, PF9462I9HX, (3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide, Vitrakvi, ARRY 470, 1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-, 1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-, ARRY-470; larotrectinib, Larotrectinib (USAN/INN), Larotrectinib [USAN:INN], ARRY470, AMY264, GTPL8909, SCHEMBL2241012, CHEMBL3889654, BDBM136597, BCP16262, EX-A1981, MFCD28902192, NSC785570, NSC801004, s5860, Larotrectinib (LOXO-101 free base), example 14 [US8865698 B2], ZINC118399834, BAY2757556, CS-5722, DB14723, NSC-785570, NSC-801004, BAY-2757556, AC-33660, AS-35231, HY-12866, J3.628.138C, D11137, US8865698, 14, Q27081513, ARRY-470;ARRY 470 : LOXO-101; LOXO101; Larotrectinib, ARRY470;ARRY-470;ARRY 470;LOXO 101;LOXO101;Larotrectinib, (3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide, (S)-N-(5 -((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin -1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3 yl)-3-hydroxypyrrolidine-1-carboxamide

Pubchem:PUBCHEM:46188928

Id:6d599261-d9ae-5060-b80f-7857104c77b8

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Larotrectinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Larotrectinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Larotrectinib.

Results found

Linked to

	Label	Description
	larotrectinib (a6617738-d4cd-43e9-bd4e-90b534cbdcc3) Collection (Entity type)	Metadatata for larotrectinib
	DCSTRUCT ID 05305 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05305; PubChem_CID:46188928, FILE=drugcentral_drug_05305.json)
	Larotrectinib bioactivity BDNF/NT-3 growth factors receptor Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Larotrectinib bioactivity High affinity nerve growth factor receptor Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Larotrectinib indication Malignant Neoplasm Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Larotrectinib bioactivity NT-3 growth factor receptor Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Larotrectinib indication Solid neoplasm with neurotrophic receptor tyrosine kinase gene fusion Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG